bms345541 and Pancreatic-Neoplasms

bms345541 has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for bms345541 and Pancreatic-Neoplasms

Article	Year
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy. European journal of medicinal chemistry, 2021, Oct-15, Volume: 222 Genetic models validated Inhibitor of nuclear factor (NF) kappa B kinase beta (IKKβ) as a therapeutic target for KRAS mutation associated pancreatic cancer. Phosphorylation of the activation loop serine residues (S Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; I-kappa B Kinase; Mice; Molecular Structure; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Quinoxalines; Structure-Activity Relationship; Urea	2021

Article

Year

Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.

European journal of medicinal chemistry, 2021, Oct-15, Volume: 222

Genetic models validated Inhibitor of nuclear factor (NF) kappa B kinase beta (IKKβ) as a therapeutic target for KRAS mutation associated pancreatic cancer. Phosphorylation of the activation loop serine residues (S

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; I-kappa B Kinase; Mice; Molecular Structure; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Quinoxalines; Structure-Activity Relationship; Urea

2021